Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma
Blood（2017）
摘要
Key Points Anti-sclerostin treatment increases bone mass and fracture resistance in MM Anti-sclerostin in combination with zoledronic acid is superior to zoledronic acid alone in increasing fracture resistance.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要